Trial to Evaluate the Safety and Tolerability of Repeated Intravitreal Injection of IBI302 in Neovascular AMD Patients
Clinical trial NCT04370379 · COMPLETED
Trial details
- NCT number
- NCT04370379
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-28
- Primary completion
- 2021-04-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.